Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MIST

Milestone Pharmaceuticals Inc

May 05 • 04:00PM ET

1.88

-0.01 -0.79 %

Healthcare • Biotechnology • Canada • Micro • NASD

Peers: ACAD BPMC KYNB RARE XENE BHVN AXSM VTGN IKT

| Held by: SURI QQQS GWX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.80	Insider Own	1.03%	Shs Outstand	117.67M	Perf Week	1.62%
Market Cap	221.21M	Forward P/E	-	EPS next Y	-0.83	Insider Trans	-30.15%	Shs Float	116.46M	Perf Month	23.68%
Enterprise Value	173.63M	PEG	-	EPS next Q	0.19	Inst Own	22.76%	Short Float	8.87%	Perf Quarter	-4.57%
Income	-63.06M	P/S	142.72	EPS this Y	42.00%	Inst Trans	-7.66%	Short Ratio	5.19	Perf Half Y	-2.08%
Sales	1.55M	P/B	4.78	EPS next Y	-90.04%	ROA	-66.71%	Short Interest	10.33M	Perf YTD	-6.93%
Book/sh	0.39	P/C	2.09	EPS next 5Y	33.31%	ROE	-229.65%	52W High	3.06 -38.56%	Perf Year	41.35%
Cash/sh	0.90	P/FCF	-	EPS past 3/5Y	18.24% 15.09%	ROIC	-63.38%	52W Low	1.00 88.00%	Perf 3Y	-47.63%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-32.38% -	Gross Margin	92.63%	Volatility	5.47% 7.96%	Perf 5Y	-66.61%
Dividend TTM	-	EV/Sales	112.02	EPS Y/Y TTM	-10.20%	Oper. Margin	-4041.72%	ATR (14)	0.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.96	Sales Y/Y TTM	-	Profit Margin	-4078.78%	RSI (14)	53.64	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	8.01	EPS Q/Q	29.26%	SMA20	-3.43%	Beta	1.04	Target Price	6.50
Payout	-	Debt/Eq	1.40	Sales Q/Q	-	SMA50	10.91%	Rel Volume	0.65	Prev Close	1.89
Employees	38	LT Debt/Eq	1.38	Earnings	Mar 20 BMO	SMA200	-0.39%	Avg Volume	1.99M	Price	1.88
IPO	May 09, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.12% -	Trades		Volume	1,317,562	Change	-0.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)